Key statistics
On Monday, Karolinska Development AB (0P3C:LSE) closed at 0.3015, 16.82% above the 52 week low of 0.2581 set on Dec 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | -- |
|---|---|
| High | 0.3015 |
| Low | 0.3015 |
| Bid | -- |
| Offer | -- |
| Previous close | 0.00 |
| Average volume | -- |
|---|---|
| Shares outstanding | 942.72m |
| Free float | 104.87m |
| P/E (TTM) | -- |
| Market cap | 311.10m SEK |
| EPS (TTM) | -0.4096 SEK |
Data delayed at least 20 minutes, as of Jan 19 2026 12:25 GMT.
More ▼
Announcements
- Year-end Report - January-December 2025
- Bokslutskommuniké för januari – december 2025
- KDventures AB (publ) carries out a directed issue of shares to guarantors in connection with the completed rights issue
- KDventures AB (publ) genomför riktad nyemission av aktier till garanter i samband med den genomförda företrädesemissionen
- KDventures´ portfolio company SVF Vaccines appoints Raheleh Nassaji as Chief Executive Officer
- KDventures portföljbolag SVF Vaccines utser Raheleh Nassaji till verkställande direktör
- Karolinska Development’s portfolio company SVF Vaccines and Novakand Pharma enters into a reverse acquisition agreement
- Karolinska Developments portföljbolag SVF Vaccines ingår avtal med Novakand Pharma om omvänt förvärv
- Karolinska Development AB (publ) announces the outcome of the rights issue and change of the company name to KDventures AB
- Karolinska Development AB (publ) offentliggör utfall i företrädesemissionen och genomför namnbyte till KDventures AB
More ▼
